NewsRoom Articles - Page 200 of 223

TuesdayOct 27, 2020 12:00 pm

Comparison Between Saliva, Swab Coronavirus Tests

From the start of the pandemic, researchers and clinicians have been searching for nasopharyngeal swab alternatives. Tests administered using these swabs are hard to scale up for mass testing, they put health workers in closer contact with individuals who may be infected, and they require more supplies. Saliva has been suggested as an easy and low-cost alternative. However, its accuracy and efficacy remain a point of conflict. Trials of saliva-based tests have been carried out in the field but produced mixed results. These results only make it harder for saliva to be used in the existing testing framework as researchers…

TuesdayOct 27, 2020 11:25 am

Strategic HCP Partnerships Virtual Summit Networking Hub for Healthcare Professionals

Virtual event set for Wednesday, Nov. 18–Friday, Nov. 20, 2020 Forum for healthcare professionals, executives of healthcare organizations and service providers Three virtual environments — exhibit hall, session areas and network rooms — offer optimal opportunity for engagement Hosted by Lincoln Health Network The Strategic HCP Partnerships Summit — a virtual event this year — is shaping up to be a networking hub for healthcare professionals, executives of healthcare organizations (HCO) and service providers. The three-day event, scheduled for Nov. 18–20, 2020, offers a platform that promises to foster engagement and provide a wealth of opportunity to build and expand…

TuesdayOct 27, 2020 10:00 am

Patent Suggests Apple Is Working on Smart Biomedical Glasses

It is commonly known that Apple is working on bettering its offerings in the wellness and health category. The company was recently awarded a patent that indicates that the firm is taking its approach into health a step further with a new invention: biomedical smart glasses. Spotted by Patently Apple, the new patent describes this invention as a head-mounted display device that can monitor certain head movements such as nodding one’s head as well as facial gestures such as closing and opening mouths. The device can also be used with other health devices, including the Apple Watch. This ability will…

MondayOct 26, 2020 12:00 pm

Is It Acceptable for Police to Seize Your Biomedical Samples?

Let’s assume you’ve acquired a grant to begin a research study to investigate the spread of a certain disease in a population. So you gather your samples, do your research and publish your findings. Then out of nowhere, law enforcement shows up with a court order to obtain a sample from your collection that will help in the legal prosecution of one of the participants of your study. As a researcher, would you find it unethical for the police to take your research samples without the participants’ consent or knowledge? In an essay authored by Nina de Groot and her…

MondayOct 26, 2020 10:00 am

Study Discovers Global Distrust for COVID-19 Vaccines

A research team made up of researchers from the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) and other distinguished institutions such as the Barcelona Institute for Global Health and the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine announced yesterday that their research, which focused on potential global hesitancy to accept a coronavirus vaccine, was published in the “Nature Medicine” journal. The researchers carried out their research based on previously collected COVID-SCORE data of more than 13,400 people from 19 countries that had been the most affected by…

FridayOct 23, 2020 3:08 pm

SPAC Merger Fires Boosters for 180 Life Sciences’ Exploration in Unmet Medical Needs of Anti-inflammatories Space

Biotechnology company 180 Life Sciences has launched a variety of advanced clinical and preclinical-stage efforts to develop novel anti-inflammatory treatments for patients with chronic illnesses A planned merger with 180 Life Sciences advanced under a special purpose acquisition corporation (SPAC) is expected to be completed within the next month, resulting in a Nasdaq filing under the ticker ATNF 180 Life Sciences’s founders are an experienced team of medical scientists who pioneered anti-inflammatory pharmaceuticals in the 1990s that are still in use today, generating billions in revenue The company’s own-IP clinical trials seek to resolve inflammation-related issues in conditions such as…

FridayOct 23, 2020 1:05 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moves Closer to IND Filing as Manufacturing of Lead Drug Candidate Commences

Berubicin Expected to Commence Trials for the Treatment of Glioblastoma, An Aggressive Form of Brain Cancer Currently Considered Incurable Production of Berubicin Begins in the U.S. and Europe Dual Manufacturing Facilities Engaged to Reduce Supply Chain Interruptions IND for Berubicin Could Be Filed by Year End CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) expects to have an Investigational New Drug Application (“IND”) ready for its lead drug candidate, Berubicin, by the end of 2020. An approved IND would give the biotech company, which is developing treatments for primary and metastatic cancers of the brain and central nervous system, the green light to…

FridayOct 23, 2020 12:00 pm

Social Distancing, Masks May Not Be Enough to Prevent Coronavirus Infection

When the pandemic began, many countries introduced guidelines to help curb the spread of the coronavirus. The most common of these included: 1. Social distancing 2. Avoiding crowds; limiting the number of people in public places 3. Wearing a mask in public However, these recommendations are based on decades-old scientific foundations that may not reflect the current state of knowledge. Consequently, several research groups have come together to develop a better and improved model of the spread of the disease’s infectious droplets. These researchers from the field of fluid dynamics have demonstrated that while it makes sense to maintain social…

FridayOct 23, 2020 10:00 am

Research Unveils Potential Link Between Blood Groups and Coronavirus Susceptibility

Last week, “Blood Advances” published two studies that suggest people with O blood type may be at a lower risk of contracting COVID-19. In addition, when these individuals do get sick, studies suggest that they have a reduced likelihood of experiencing organ complications or other serious outcomes. With the ongoing pandemic, the biomedical research community is working diligently to identify potential therapeutic targets and coronavirus risk factors. The role of blood types in predicting the risks and complications of a coronavirus infection in an individual has been identified as a fundamental question. The new studies add to the existing knowledge…

ThursdayOct 22, 2020 12:00 pm

Pioneer Study Discovers Link Between Lowered Neuroplasticity and Obesity

A pioneer study carried out by researchers from the University of South Australia discovered that individuals who are severely overweight are less likely to be able to create new neural pathways and re-wire their brains. This discovery will have significant implications for people who are recovering from brain injuries or a stroke. The paper, written by researchers from Deakin University and University of South Australia, was published in “Brain Sciences.” The research showed that in obese people, brain plasticity is impaired. This makes it less likely for them to remember things or learn new tasks. The study used a series…